Princeton University: It's All in Delivery -- Nanoparticle Platform Could Transform Medical Treatments
February 13, 2020
February 13, 2020
PRINCETON, New Jersey, Feb. 13 -- Princeton University issued the following news release:
Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The collaborations have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.
Optimeos, found . . .
Optimeos Life Sciences, a startup founded by two Princeton University faculty members, has reached agreements with six pharmaceutical companies to develop therapeutics using a Princeton-developed drug delivery technology. The collaborations have the potential to improve the effectiveness of medications for the treatment of diseases, ranging from cancer to diabetes.
Optimeos, found . . .